|
Treatment
|
1st h
|
2nd h
|
3rd h
|
4th h
|
5th h
|
|---|
|
Group 1 Saline
|
0.247 ± 0.026
|
0.250 ± 0.022
|
0.265 ± 0.013
|
0.250 ± 0.014
|
0.250 ± 0.016
|
|
Group 2 Carrageenan
|
0.355 ± 0.013###
|
0.370 ± 0.026###
|
0.385 ± 0.021###
|
0.397 ± 0.026###
|
0.405 ± 0.013###
|
|
Group 3 Diclofenac (50 mg/kg)
|
0.287 ± 0.029**
|
0.265 ± 0.019***
|
0.265 ± 0.031***
|
0.287 ± 0.025***
|
0.305 ± 0.012***
|
|
Group 4 Gum (200 mg/kg)
|
0.302 ± 0.009*
|
0.290 ± 0.008***
|
0.295 ± 0.013***
|
0.305 ± 0.013***
|
0.315 ± 0.019***
|
|
Group 5 Gum (400 mg/kg)
|
0.282 ± 0.017***
|
0.292 ± 0.012***
|
0.287 ± 0.012***
|
0.280 ± 0.022***
|
0.290 ± 0.018***
|
|
Group 6 Gold nanoparticles (40 mg/kg)
|
0.305 ± 0.021*
|
0.307 ± 0.012***
|
0.305 ± 0.012***
|
0.302 ± 0.015***
|
0.317 ± 0.026***
|
|
Group 7 Gold nanoparticles (80 mg/kg)
|
0.295 ± 0.013**
|
0.287 ± 0.017***
|
0.295 ± 0.013***
|
0.287 ± 0.022***
|
0.300 ± 0.018***
|
- Values expressed as mean paw volume in mL ± SD. ###
P <0.001 compared to group 1. *
P <0.05, **
P <0.01, ***
P <0.001 compared to group 2. One-way ANOVA followed by Tukey’s post hoc test. Results are the means of 6 animals per group
